These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 9480814)

  • 1. Role of AP-1 complex in angiotensin II-mediated transforming growth factor-beta expression and growth of smooth muscle cells: using decoy approach against AP-1 binding site.
    Morishita R; Gibbons GH; Horiuchi M; Kaneda Y; Ogihara T; Dzau VJ
    Biochem Biophys Res Commun; 1998 Feb; 243(2):361-7. PubMed ID: 9480814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II induces human TGF-beta 1 promoter activation: similarity to hyperglycaemia.
    Weigert C; Brodbeck K; Klopfer K; Häring HU; Schleicher ED
    Diabetologia; 2002 Jun; 45(6):890-8. PubMed ID: 12107734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcription factor decoy for AP-1 reduces mesangial cell proliferation and extracellular matrix production in vitro and in vivo.
    Ahn JD; Morishita R; Kaneda Y; Kim HJ; Kim YD; Lee HJ; Lee KU; Park JY; Kim YH; Park KK; Chang YC; Yoon KH; Kwon HS; Park KG; Lee IK
    Gene Ther; 2004 Jun; 11(11):916-23. PubMed ID: 14961072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autocrine TGF-beta1 mediates angiotensin II-induced proliferative response of cerebral vessels in vivo.
    Yurovsky VV; Gerzanich V; Ivanova S; Dong Y; Tsymbalyuk O; Simard JM
    Am J Hypertens; 2007 Sep; 20(9):950-6. PubMed ID: 17765135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AP-1 transcription factor decoy reduces the TGF-beta1-induced cell growth in scleroderma fibroblasts through inhibition of cyclin E.
    Cho JW; Cha YC; Lee KS
    Oncol Rep; 2008 Mar; 19(3):737-41. PubMed ID: 18288409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Activating protein-1 complex regulates oxidized low density lipoprotein-induced overproduction of rat TGF-beta1 at transcriptional level].
    Zhou Q; Lan Y; Wang Y; Zhao Y; Wu Z
    Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(19):1346-50. PubMed ID: 12509941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II modulates frizzled-2 receptor expression in rat vascular smooth muscle cells.
    Castoldi G; Redaelli S; van de Greef WM; di Gioia CR; Busca G; Sperti G; Stella A
    Clin Sci (Lond); 2005 Jun; 108(6):523-30. PubMed ID: 15667337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetaldehyde stimulates the activation of latent transforming growth factor-beta1 and induces expression of the type II receptor of the cytokine in rat cultured hepatic stellate cells.
    Chen A
    Biochem J; 2002 Dec; 368(Pt 3):683-93. PubMed ID: 12223100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II enhances interleukin-18 mediated inflammatory gene expression in vascular smooth muscle cells: a novel cross-talk in the pathogenesis of atherosclerosis.
    Sahar S; Dwarakanath RS; Reddy MA; Lanting L; Todorov I; Natarajan R
    Circ Res; 2005 May; 96(10):1064-71. PubMed ID: 15860756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small interfering RNA knocks down heat shock factor-1 (HSF-1) and exacerbates pro-inflammatory activation of NF-kappaB and AP-1 in vascular smooth muscle cells.
    Chen Y; Currie RW
    Cardiovasc Res; 2006 Jan; 69(1):66-75. PubMed ID: 16061216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcription factor decoy for activator protein-1 (AP-1) inhibits high glucose- and angiotensin II-induced type 1 plasminogen activator inhibitor (PAI-1) gene expression in cultured human vascular smooth muscle cells.
    Ahn JD; Morishita R; Kaneda Y; Lee KU; Park JY; Jeon YJ; Song HS; Lee IK
    Diabetologia; 2001 Jun; 44(6):713-20. PubMed ID: 11440364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quercetin glucuronide prevents VSMC hypertrophy by angiotensin II via the inhibition of JNK and AP-1 signaling pathway.
    Yoshizumi M; Tsuchiya K; Suzaki Y; Kirima K; Kyaw M; Moon JH; Terao J; Tamaki T
    Biochem Biophys Res Commun; 2002 May; 293(5):1458-65. PubMed ID: 12054679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-talk between aldosterone and angiotensin II in vascular smooth muscle cell senescence.
    Min LJ; Mogi M; Iwanami J; Li JM; Sakata A; Fujita T; Tsukuda K; Iwai M; Horiuchi M
    Cardiovasc Res; 2007 Dec; 76(3):506-16. PubMed ID: 17706954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antisense targeting of c-fos transcripts inhibits serum- and TGF-beta 1-stimulated PAI-1 gene expression and directed motility in renal epithelial cells.
    Kutz SM; Providence KM; Higgins PJ
    Cell Motil Cytoskeleton; 2001 Mar; 48(3):163-74. PubMed ID: 11223948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal regulation of transforming growth factor-beta receptors on vascular smooth muscle cells from spontaneously hypertensive rats by angiotensin II.
    Fukuda N; Hu WY; Kubo A; Endoh M; Kishioka H; Satoh C; Soma M; Izumi Y; Kanmatsuse K
    Hypertension; 1998 Feb; 31(2):672-7. PubMed ID: 9461239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AP-1 complexes mediate oxidized LDL-induced overproduction of TGF-beta(1) in rat mesangial cells.
    Wu Z; Zhou Q; Lan Y; Wang Y; Xu X; Jin H
    Cell Biochem Funct; 2004; 22(4):237-47. PubMed ID: 15248184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II.
    Gibbons GH; Pratt RE; Dzau VJ
    J Clin Invest; 1992 Aug; 90(2):456-61. PubMed ID: 1644917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGF-beta inhibits Ang II-induced MAPK p44/42 signaling in vascular smooth muscle cells by Ang II type 1 receptor downregulation.
    Meijering BD; van der Wouden EA; Pelgröm V; Henning RH; Sharma K; Deelman LE
    J Vasc Res; 2009; 46(5):459-68. PubMed ID: 19204403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of thrombospondin expression in vascular smooth muscle cells by angiotensin II.
    Scott-Burden T; Resink TJ; Hahn AW; Bühler FR
    J Cardiovasc Pharmacol; 1990; 16 Suppl 7():S17-20. PubMed ID: 1708015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of extracellular signal-regulated kinase to angiotensin II-induced transforming growth factor-beta1 expression in vascular smooth muscle cells.
    Hamaguchi A; Kim S; Izumi Y; Zhan Y; Yamanaka S; Iwao H
    Hypertension; 1999 Jul; 34(1):126-31. PubMed ID: 10406835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.